Naushad Shaik is a Cardiology physician affiliated with AdventHealth Orlando. OpenAlex indexes 21 publications with 818 citations (h-index 10); ClinicalTrials.gov lists 1 registered study matched to this name.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
601 Oak Commons Blvd
Kissimmee, FL 347414213
Telephone
407-846-0626Registry record last updated 16 Feb 2017.
Clinical trials
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Industry payments
38 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Boston Scientific CorporationProgram year2025142 payments$103,504openpaymentsdata.cms.gov ↗
- BIOTRONIK INC.Program year202522 payments$19,339openpaymentsdata.cms.gov ↗
- Abbott LaboratoriesProgram year202515 payments$13,092openpaymentsdata.cms.gov ↗
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cardiovascular
72.9%Beta blocker24.8%Metoprolol Succinate54%Carvedilol21%Metoprolol Tartrate17%Sotalol6%Bisoprolol Fumarate2%Part D<11 patientsStatin11.9%Atorvastatin Calcium38%Pravastatin Sodium25%Rosuvastatin Calcium24%Simvastatin13%Part D≥47 patients+ 12 more classes in this area
Blood & clotting
22.1%Factor Xa inhibitor18.4%Eliquis77%Xarelto23%Part D≥112 patientsP2Y12 inhibitor3.7%Clopidogrel100%Part D≥50 patientsMetabolism & gastrointestinal
5.1%Proton pump inhibitor2.1%Pantoprazole Sodium78%Omeprazole22%Part D<11 patientsSGLT2 inhibitor1.7%Jardiance74%Farxiga26%Part D<11 patients+ 2 more classes in this area
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Multicenter Study on the Safety of Pulsed Field Ablation in Over 40,000 Patients
Journal of the American College of Cardiology
2025
Similar KOLs
Other experts from the same institution or the same specialty.
Tarek Mekhail, MD
AdventHealth Orlando
Bridget Koontz, MD
AdventHealth Orlando
Ayman Koteish, MD
AdventHealth Orlando
Chandra Bomma, MD
AdventHealth Orlando
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”